CoverageForm 410-K10-Q8-K13D13G13F

SUMR · Summer Infant, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemQ1 '22Q3 '21Q2 '21Q1 '21Q3 '20Q2 '20Q1 '20Q4 '19Q3 '19Q2 '19
Revenue$34.38M$41.55M$30.60M$36.20M$40.70M$38.21M$40.34M-$41.52M$46.42M
Cost of Revenue$27.11M$29.78M$20.94M$25.54M$27.17M$24.18M$27.84M-$28.93M$31.58M
Gross Profit$7.27M$11.77M$9.67M$10.66M$13.54M$14.04M$12.50M-$12.60M$14.84M
R&D----------
SG&A$7.95M$7.12M$6.79M$7.03M$6.89M$6.73M$8.15M-$8.35M$8.52M
Total Operating Expenses----------
D&A$561.0K$555.0K$560.0K$560.0K$783.0K$813.0K$967.0K-$1.01M$952.0K
Operating Income($3.50M)$982.0K($142.0K)$663.0K$3.06M$2.76M($55.0K)-($274.0K)$1.34M
Interest Expense----------
Income Tax-$383.0K$149.0K$67.0K($166.0K)$351.0K($255.0K)-$195.0K$267.0K
Net Income($3.92M)$252.0K$1.35M$260.0K$2.21M$1.29M($1.21M)-($1.66M)($224.0K)
EPS - Basic($1.81)$0.12$0.63$0.12$1.04$0.61($0.57)-($0.09)($0.01)
EPS - Diluted($1.81)$0.12$0.62$0.12$1.03$0.61($0.57)-($0.09)($0.01)

Balance Sheet

Line itemQ1 '22Q3 '21Q2 '21Q1 '21Q3 '20Q2 '20Q1 '20Q4 '19Q3 '19Q2 '19
Cash & Equivalents$598.0K$389.0K$457.0K$447.0K$871.0K$848.0K$693.0K$395.0K$659.0K$580.0K
Accounts Receivable$28.80M$34.45M$23.80M$28.61M$30.76M$28.04M$30.47M$32.79M$29.68M$35.98M
Inventory$21.97M$24.65M$18.20M$16.55M$24.46M$18.83M$25.17M$28.06M$30.16M$32.60M
Accounts Payable$22.55M$25.76M$21.08M$21.62M$29.46M$24.25M$25.53M$25.40M$24.48M$24.68M
Current Assets$53.39M$60.63M$43.72M$47.10M$58.90M$51.61M$59.37M$64.18M$61.81M$70.38M
Total Assets$82.09M$92.04M$76.19M$80.86M$82.66M$76.19M$85.58M$91.54M$91.01M$100.68M
Current Liabilities$36.59M$38.50M$31.01M$33.03M$40.85M$35.77M$35.72M$36.05M$34.12M$35.62M
Long-term Debt$33.54M$33.40M$24.51M$26.40M$32.13M$32.38M$41.76M$45.36M$45.47M$51.25M
Total Liabilities$83.37M$84.73M$69.11M$75.52M$74.61M$70.50M$81.27M$85.96M$84.68M$92.66M
Stockholders' Equity($1.28M)$7.31M$7.08M$5.34M$8.05M$5.68M$4.31M$5.58M$11.50M$8.01M
Retained Earnings($77.00M)($68.32M)($68.58M)($69.93M)($66.80M)($69.01M)($70.30M)($69.09M)($67.17M)($65.51M)

Cash Flow

Line itemQ1 '22Q3 '21Q2 '21Q1 '21Q3 '20Q2 '20Q1 '20Q4 '19Q3 '19Q2 '19
Operating Cash Flow$2.08M--$1.32M--$4.89M---
Investing Cash Flow($44.0K)--($191.0K)--($245.0K)---
Financing Cash Flow($2.01M)--($1.18M)--($4.52M)---
CapEx$32.0K--$191.0K--$220.0K---
Free Cash Flow$2.05M--$1.13M--$4.67M---

Ratios

MetricQ1 '22Q3 '21Q2 '21Q1 '21Q3 '20Q2 '20Q1 '20Q4 '19Q3 '19Q2 '19
Profitability
Gross margin21.1%28.3%31.6%29.4%33.3%36.7%31.0%-30.3%32.0%
Operating margin-10.2%2.4%-0.5%1.8%7.5%7.2%-0.1%--0.7%2.9%
EBITDA margin-8.6%3.7%1.4%3.4%9.4%9.3%2.3%-1.8%4.9%
Net margin-11.4%0.6%4.4%0.7%5.4%3.4%-3.0%--4.0%-0.5%
Free cash flow margin6.0%--3.1%--11.6%---
FCF / Net income-0.52--4.35---3.86---
R&D / Revenue----------
SG&A / Revenue23.1%17.1%22.2%19.4%16.9%17.6%20.2%-20.1%18.4%
Effective tax rate-60.3%9.9%20.5%-8.1%21.4%---620.9%
Return on assets-4.8%0.3%1.8%0.3%2.7%1.7%-1.4%--1.8%-0.2%
Return on equity305.6%3.4%19.1%4.9%27.5%22.6%-28.1%--14.4%-2.8%
Return on invested capital-1.2%-0.4%1.7%7.6%5.7%-0.1%--0.4%1.1%
Liquidity
Current ratio1.461.571.411.431.441.441.661.781.811.98
Quick ratio0.860.930.820.920.840.920.961.000.931.06
Cash ratio0.020.010.010.010.020.020.020.010.020.02
Leverage
Debt / Equity-26.184.573.464.943.995.709.708.123.956.40
Debt / Assets0.410.360.320.330.390.430.490.500.500.51
Debt / EBITDA-21.7358.6421.598.369.0645.79-61.6122.40
Interest coverage----------
Equity multiplier-64.0812.5910.7615.1310.2713.4019.8716.407.9112.56
Liabilities / Assets1.020.920.910.930.900.930.950.940.930.92
Efficiency
Asset turnover0.420.450.400.450.490.500.47-0.460.46
Inventory turnover1.231.211.151.541.111.281.11-0.960.97
Days sales outstanding306d303d284d288d276d268d276d-261d283d
Days inventory outstanding296d302d317d237d329d284d330d-381d377d
Days payable outstanding304d316d368d309d396d366d335d-309d285d
Cash conversion cycle298d289d234d216d209d186d271d-333d374d
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)-5.0%2.1%-19.9%-10.3%-2.0%-17.7%-4.1%---
Revenue CAGR (3y)-6.5%---------
Revenue CAGR (5y)----------
Gross profit growth (YoY)-31.8%-13.0%-31.1%-14.8%7.5%-5.4%-7.0%--7.5%-3.6%
Operating income growth (YoY)--67.9%---106.5%74.9%---27.9%
Net income growth (YoY)--88.6%5.3%---13.4%---
EPS growth (YoY)--88.3%1.6%----714.3%---
EPS CAGR (3y)-128.9%214.1%--172.9%----
EPS CAGR (5y)-64.4%128.3%-------
FCF growth (YoY)81.2%---75.8%------
FCF CAGR (5y)----27.7%--3.3%---
Book value growth (YoY)--9.1%24.5%24.1%-30.0%-29.1%-46.7%-39.8%0.0%-28.2%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2022-01-01.

Geographic

$143.66M total
US$132.15M · 92.0%
Canada Europe South America Mexico Asia And Middle East$11.51M · 8.0%

Peer comparison

Same SIC group: Miscellaneous Manufacturing Industries

CompanyRevenue (last FY)Net marginROE
HI$2.67B1.6%3.1%
BRC---
DAKT---
AMCR$15.01B3.4%4.4%
ODC$485.57M11.1%20.8%

Comparing Summer Infant against the 5 most active filers in the same SIC group.